Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis: Geo Neul Park, Kyung Ho Lee, Ji Eun Moon et al.; Received March 28, 2023 Accepted September 5, 2023 Published online January 23, 2024; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Review Articles

Pleotropic effects of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors: are they clinically relevant?: Yu-Hsiang Chou, Szu-Yu Pan, Shuei-Liong Lin; Kidney Res Clin Pract. 2023;42(1):27-38. Published online November 21, 2022; DOI: https://doi.org/10.23876/j.krcp.22.118
Web of Science 2 Cited By 5; Full text PubReader ePub PDF

Original Articles

Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: reduction of erythropoietin dose in 4 years of follow-up: Antonio Lacquaniti, Patrizio Pasqualetti, Teresa Casuscelli di Tocco et al.; Kidney Res Clin Pract. 2020;39(3):334-343. Published online September 30, 2020; DOI: https://doi.org/10.23876/j.krcp.20.015
Web of Science 8 Cited By 8; Full text PubReader PDF

Drug treatment patterns and work productivity in chronic kidney disease patients with anemia in China: cross sectional analysis of real-world data: Heleen van Haalen, James Sloand, Rebecca Moon et al.; Kidney Res Clin Pract. 2020;39(3):318-333. Published online September 30, 2020; DOI: https://doi.org/10.23876/j.krcp.20.020
Web of Science 2 Cited By 2; Full text PubReader PDF

Effects of online hemodiafiltration on anemia and nutritional status in chronic hemodialysis patients: Yu Ho Lee, Yoon Soo Shin, So-Young Lee et al.; Kidney Res Clin Pract. 2020;39(1):103-111. Published online March 31, 2020; DOI: https://doi.org/10.23876/j.krcp.19.082
Web of Science 6 Cited By 7; Full text PubReader PDF

Review Article

Treatment of renal anemia: Erythropoiesis stimulating agents and beyond: Patrick Biggar, Gheun-Ho Kim; Kidney Res Clin Pract. 2017;36(3):209-223. Published online September 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.3.209
Web of Science 24 Cited By 21; Full text PubReader PDF

Images in Practice

Posterior nutcracker phenomenon with Down syndrome: Eun Sil Koh, Min Young Kim, Yoon Sik Chang, Sungjin Chung; Kidney Res Clin Pract. 2015;34(4):245-246. Published online November 12, 2015; DOI: https://doi.org/10.1016/j.krcp.2015.10.001
Web of Science 2 Cited By 3; Full text PubReader PDF

Original Articles

Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients: Mi Yeon Jung, Soon Young Hwang, Yu Ah Hong et al.; Kidney Res Clin Pract. 2015;34(1):20-27. Published online January 15, 2015; DOI: https://doi.org/10.1016/j.krcp.2014.11.003
Web of Science 9 Cited By 9; Full text PubReader PDF

A randomized crossover study of single biweekly administration of epoetin-α compared with darbepoetin-α in chronic kidney disease patients not receiving dialysis: Ha-Young Na, Yong-Kyu Lee, Sug-Kyun Shin et al.; Kidney Res Clin Pract. 2014;33(4):210-216. Published online December 5, 2014; DOI: https://doi.org/10.1016/j.krcp.2014.10.001
Web of Science 1 Cited By 2; Full text PubReader PDF

Review Articles

Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease: Derek S. Larson, Daniel W. Coyne; Kidney Res Clin Pract. 2013;32(1):11-15. Published online January 16, 2013; DOI: https://doi.org/10.1016/j.krcp.2013.01.001
Cited By 12; Full text PubReader PDF

Original Articles

The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia: Dae Woong Kang, Chi Yong Ahn, Bong Kwan Ryu, Byung Chul Shin, Jong Hoon Chung, Hyun Lee Kim; Kidney Res Clin Pract. 2012;31(1):48-53. Published online January 20, 2012; DOI: https://doi.org/10.1016/j.krcp.2012.01.002
Web of Science 5 Cited By 6; Full text PubReader PDF

Lupus Cystitis and Azathioprine-iIduced Pure Red Cell Aplasia in a Patient with Systemic Lupus Erythematosus: Tai Yeon Koo Hyun Jung Kim Kyung Min Kim Dong Kyu Oh Geum Borae Park and Sang Koo Lee; Korean J Nephrol. 2011;30(1):102-106.; PDF

Hemoglobin Variability Associated with Different Erythropoiesis Stimulating Agents in Hemodialysis Patients: Su-Kyoung Park, Kyu Sig Hwang, Joon-Sung Park, Chang-Hwa Lee, Chong Myung Kang and Gheun-Ho Kim; Korean J Nephrol. 2011;30(1):41-47.; PDF

Comparison of Once-Biweekly Administration of Epoetin-α with Darbepoetin-α in Chronic Kidney Disease Patients Not Receiving Dialysis: So-Young Kim, M.D., Hae-Jin Choi, M.D., Hye-Jin Choi, M.D., Cho-ee Lee, M.D., Seon-Ung Yun, M.D., Jung-Hwan Park, M.D., Jong-Ho Lee, M.D., Jong-Oh Song, M.D. and Young-Il Jo, M.D.; Korean J Nephrol. 2010;29(5):562-569.; PDF

Comparison of Erythropoietic Effect between Epoetin-α and Darbepoetin-α in Hemodialysis Patients: A Randomized Crossover Study: Ji Young Lee, M.D., Seung Woon Byun, M.D., Young Sun Yeo, M.D., Won Seok Yang, M.D., Su-Kil Park, M.D., Jung Sik Park, M.D. and Jai Won Chang, M.D.; Korean J Nephrol. 2009;28(5):450-455.; PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

15,122	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
20,032	C4d Puzzle in ABO-incompatible kidney transplantation
8,636	How should we treat acute kidney injury caused by renal congestion?
35,508	Uremic pruritus: pathophysiology, clinical presentation, and treatments
13,278	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options

Cited By 15	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.